A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients
Status:
COMPLETED
Trial end date:
2024-07-18
Target enrollment:
Participant gender:
Summary
Subjects having mild-to-severe plaque psoriasis, with active target lesion plaques, and currently on or starting a prescription treatment for plaque psoriasis will apply a topical skincare regimen to one side of the body. Evaluations of the regimen's efficacy will be conducted at 2 weeks, 4 weeks, and 8 weeks post-baseline.